Arimoto Takanori, Watanabe Eiichi, Kohno Ritsuko, Shimeno Kenji, Kikuchi Kan, Doi Atsushi, Inoue Kanki, Nitta Takashi, Nogami Akihiko, Abe Haruhiko, Okumura Ken
Department of Cardiology Yamagata University School of Medicine Yamagata Japan.
Department of Cardiology Fujita Health University Bantane Hospital Nagoya Japan.
J Arrhythm. 2020 Dec 9;37(1):182-188. doi: 10.1002/joa3.12459. eCollection 2021 Feb.
Functional capacity (FC) correlates with mortality in various cardiovascular diseases. The aim of this study was to examine whether cardiac pacemaker implantations improve the FC and affect the prognosis.
We prospectively enrolled 621 de novo pacemaker recipients (age 76 ± 9 years, 50.7% male). The FC was assessed by metabolic equivalents (METs) during the implantation and periodically thereafter. The patients were a priori classified into poor FC (<2 METs, n = 40), moderate FC (2 ≤ METs < 4, n = 239), and good FC (≥4 METs, n = 342). Three months after the pacemaker implantation, poor FC or moderate FC patients improved to a good FC by 43%. The distribution of the three FCs remained at those levels until after 1 year of follow-up ( = .18). During a median follow-up of 2.4 years, 71 patients (11%) had cardiovascular hospitalizations and 35 (5.6%) all-cause death. A multivariate Cox analysis revealed that a poor FC at baseline was an independent predictor of both cardiovascular hospitalization (hazard ratio [HR] 2.494, = .012) and all-cause death (HR 3.338, = .016). One year after the pacemaker implantation, the eight who remained with a poor FC had a high mortality rate of 37.5% ( < .01).
Approximately half of the poor or moderate FC patients improved to good FC 3 months after the pacemaker implantation. The baseline FC predicted the prognosis, and patients with an improved FC after the pacemaker implantation had a better prognosis.
功能能力(FC)与多种心血管疾病的死亡率相关。本研究的目的是检验心脏起搏器植入是否能改善功能能力并影响预后。
我们前瞻性纳入了621例初次接受起搏器植入的患者(年龄76±9岁,男性占50.7%)。在植入时及此后定期通过代谢当量(METs)评估功能能力。患者预先被分为功能能力差组(<2 METs,n = 40)、功能能力中等组(2≤METs<4,n = 239)和功能能力良好组(≥4 METs,n = 342)。起搏器植入后3个月,功能能力差或中等的患者中有43%改善为功能能力良好。这三种功能能力水平的分布在随访1年后仍保持在这些水平(P = 0.18)。在中位随访2.4年期间,71例患者(11%)有心血管住院治疗,35例(5.6%)全因死亡。多因素Cox分析显示,基线时功能能力差是心血管住院(风险比[HR] 2.494,P = 0.012)和全因死亡(HR 3.338,P = 0.016)的独立预测因素。起搏器植入1年后,仍处于功能能力差的8例患者死亡率高达37.5%(P<0.01)。
约一半功能能力差或中等的患者在起搏器植入后3个月改善为功能能力良好。基线功能能力可预测预后,起搏器植入后功能能力改善的患者预后更好。